Cure8 research brief
People with IBD already have a higher baseline risk of colorectal cancer. This study finds that having multiple first‑degree relatives with CRC adds the largest absolute additional risk, which could affect how surveillance is prioritized.
Adults with IBD, gastroenterologists and clinicians responsible for CRC surveillance, genetic counselors, and researchers in CRC risk stratification.
The researchers followed over 124,000 people with IBD and over 1.2 million matched comparators for a median of 11 years using national registers and counted CRC events.
Overall CRC incidence was higher in people with IBD than in comparators, but when comparing groups with the same family history the absolute increase from family history was similar in IBD and non-IBD groups. The largest absolute risk increase was seen in people with two or more affected first-degree relatives.
Summary is based on the abstract available via PubMed (Gastroenterology). The study is a large nationwide register-based cohort (1996–2023) reporting incidence rates and absolute risk differences; it raises a possible implication for surveillance strategies but does not itself change guidelines. The abstract does not provide detailed surveillance protocol recommendations.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Chronic inflammation in Crohn’s, especially when the colon is affected, raises colorectal cancer risk over time. Knowing risk factors and recommended screening helps people with Crohn’s get earlier detection and...
People with celiac disease may have higher risks for several digestive cancers and for inflammatory bowel diseases (Crohn’s and UC) according to this large French cohort study. Knowing these associations can help...
People with Crohn's disease and their clinicians often ask how different treatments affect cancer risk. This large nationwide study provides real-world estimates of absolute excess cancer cases by treatment group, which...
